Approval · Notice of Compliance 10083 · 2009
ALDARA: Notice of Compliance 10083
Issued March 11, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10083
- Date
- March 11, 2009
- Company
- Graceway PharmaceuticalsLondon, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product monograph
- Therapeutic class
- Immune response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALDARA | Not yet assigned | — |
Medicinal ingredients
- IMIQUIMOD 50 MG per G